Sage Therapeutics, Inc.
US ˙ NasdaqGM ˙ US78667J1088
QUESTO SIMBOLO NON E' PIU' ATTIVO

SecuritySAGE / Sage Therapeutics, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership9,250 shares
Latest Disclosed Value $ 362,230
Jefferies Group LLC ownership in SAGE / Sage Therapeutics, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 9,250 shares of Sage Therapeutics, Inc. (US:SAGE) valued at $362,230 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 9,250 shares of Sage Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $80,290 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (SAGE) in the form of stock options. The firm currently holds call options representing 37,800 of underlying shares valued at $1,480,248 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SAGE / Sage Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 SAGE THERAPEUTICS COM 78667J108 9,250 0 0.00 362 21.48 0.0030
2022-11-14 2022-09-30 13F SAGE THERAPEUTICS COM 78667J108 9,250 0 362 0.0029
2023-09-21 2022-06-30 13F/A-1 SAGE THERAPEUTICS COM 78667J108 9,250 4,750 105.56 299 101.35 0.0025
2022-08-15 2022-06-30 13F SAGE THERAPEUTICS COM 78667J108 9,250 4,750 299 0.0023
2023-09-21 2022-03-31 13F/A-1 SAGE THERAPEUTICS COM 78667J108 4,500 1,994 79.57 149 39.62 0.0009
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM 78667J108 6,144 3,638 148 0.0009
2023-09-21 2021-12-31 13F/A-1 SAGE THERAPEUTICS COM 78667J108 2,506 -1,494 -37.35 107 -40.11 0.0006
2022-02-14 2021-12-31 13F SAGE THERAPEUTICS COM 78667J108 2,506 -1,494 107 0.0006
2023-09-21 2021-09-30 13F/A-2 SAGE THERAPEUTICS COM 78667J108 4,000 -20,878 -83.92 177 -87.47 0.0013
2021-12-17 2021-09-30 13F/A-1 SAGE THERAPEUTICS COM 78667J108 4,000 -20,878 177 0.0012
2021-11-15 2021-09-30 13F SAGE THERAPEUTICS COM 78667J108 4,000 -20,878 177 0.0011
2023-09-21 2021-06-30 13F/A-2 SAGE THERAPEUTICS COM 78667J108 24,878 5,878 30.94 1,413 -0.63 0.0089
2021-08-20 2021-06-30 13F/A-1 SAGE THERAPEUTICS COM 78667J108 24,878 5,878 1,413 0.0084
2021-08-16 2021-06-30 13F SAGE THERAPEUTICS COM 78667J108 24,878 5,878 1,413 0.0084
2023-09-21 2021-03-31 13F/A-1 SAGE THERAPEUTICS COM 78667J108 19,000 1,000 5.56 1,422 -8.67 0.0125
2021-05-14 2021-03-31 13F SAGE THERAPEUTICS COM 78667J108 19,000 1,000 1,422 0.0125
2023-09-21 2020-12-31 13F/A-1 SAGE THERAPEUTICS COM 78667J108 18,000 -9,500 -34.55 1,557 -7.38 0.0122
2021-02-16 2020-12-31 13F SAGE THERAPEUTICS COM 78667J108 18,000 -9,500 1,557 0.0140
2020-11-13 2020-09-30 13F SAGE THERAPEUTICS COM 78667J108 27,500 -7,500 -21.43 1,681 15.53 0.0186
2020-11-02 2020-06-30 13F/A-1 SAGE THERAPEUTICS COM 78667J108 35,000 24,635 237.67 1,455 388.26 0.0171
2020-08-14 2020-06-30 13F SAGE THERAPEUTICS COM 78667J108 35,000 24,635 1,455 19,552.0787
2020-05-15 2020-03-31 13F SAGE THERAPEUTICS COM 78667J108 10,365 -6,253 -37.63 298 -75.17 0.0037
2020-02-13 2019-12-31 13F SAGE THERAPEUTICS COM 78667J108 16,618 3,394 25.67 1,200 -35.31 0.0093
2019-11-13 2019-09-30 13F SAGE THERAPEUTICS COM 78667J108 13,224 3,295 33.19 1,855 2.04 0.0144
2019-08-14 2019-06-30 13F SAGE THERAPEUTICS COM 78667J108 9,929 -6,571 -39.82 1,818 -30.72 0.0133
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM 78667J108 16,500 9,047 121.39 2,624 267.51 0.0216
2019-02-14 2018-12-31 13F SAGE THERAPEUTICS COM 78667J108 7,453 7,453 714 0.0058
2017-11-14 2017-09-30 13F SAGE THERAPEUTICS COM 78667J108 0 -14,000 -100.00 0 -100.00
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM 78667J108 14,000 14,000 1,115 0.0074
2017-02-14 2016-12-31 13F/A-1 SAGE THERAPEUTICS COM 78667J108 0 -26,326 -100.00 0 -100.00
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM 78667J108 26,326 -16,784 -38.93 1,212 -6.70 0.0063
2016-08-12 2016-06-30 13F SAGE THERAPEUTICS COM 78667J108 43,110 43,110 1,299 0.0059
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A SAGE THERAPEUTICS COM Call 37,800 51.20 1,480 83.40 n/a n/a n/a
2022-11-14 2022-09-30 13F SAGE THERAPEUTICS COM Call 37,800 1,480 n/a n/a n/a
2023-09-21 2022-06-30 13F/A SAGE THERAPEUTICS COM Call 25,000 0.00 808 -2.42 n/a n/a n/a
2022-08-15 2022-06-30 13F SAGE THERAPEUTICS COM Call 25,000 808 n/a n/a n/a
2023-09-21 2022-03-31 13F/A SAGE THERAPEUTICS COM Call 25,000 400.00 828 290.09 n/a n/a n/a
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM Call 25,000 828 n/a n/a n/a
2023-09-21 2021-12-31 13F/A SAGE THERAPEUTICS COM Call 5,000 0.00 213 -4.07 n/a n/a n/a
2022-02-14 2021-12-31 13F SAGE THERAPEUTICS COM Call 5,000 213 n/a n/a n/a
2021-12-17 2021-09-30 13F/A SAGE THERAPEUTICS COM Call 5,000 222 n/a n/a n/a
2023-09-21 2021-09-30 13F/A SAGE THERAPEUTICS COM Call 5,000 -79.59 222 -84.11 n/a n/a n/a
2021-11-15 2021-09-30 13F SAGE THERAPEUTICS COM Call 5,000 222 n/a n/a n/a
2021-08-20 2021-06-30 13F/A SAGE THERAPEUTICS COM Call 24,500 1,392 n/a n/a n/a
2023-09-21 2021-06-30 13F/A SAGE THERAPEUTICS COM Call 24,500 -46.15 1,392 -59.15 n/a n/a n/a
2021-08-16 2021-06-30 13F SAGE THERAPEUTICS COM Call 2,450,000 1,392 n/a n/a n/a
2023-09-21 2021-03-31 13F/A SAGE THERAPEUTICS COM Call 45,500 59.65 3,406 38.13 n/a n/a n/a
2021-05-14 2021-03-31 13F SAGE THERAPEUTICS COM Call 45,500 3,406 n/a n/a n/a
2023-09-21 2020-12-31 13F/A SAGE THERAPEUTICS COM Call 28,500 0.00 2,466 41.50 n/a n/a n/a
2021-02-16 2020-12-31 13F SAGE THERAPEUTICS COM Call 28,500 2,466 n/a n/a n/a
2020-11-13 2020-09-30 13F SAGE THERAPEUTICS COM Call 28,500 1,742 n/a n/a n/a
2020-05-15 2020-03-31 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F SAGE THERAPEUTICS COM Call 108,500 89.35 7,833 -2.56 n/a n/a n/a
2019-11-13 2019-09-30 13F SAGE THERAPEUTICS COM Call 57,300 -24.61 8,039 -42.23 n/a n/a n/a
2019-08-14 2019-06-30 13F SAGE THERAPEUTICS COM Call 76,000 18.20 13,915 36.06 n/a n/a n/a
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM Call 64,300 20.41 10,227 99.94 n/a n/a n/a
2019-02-14 2018-12-31 13F SAGE THERAPEUTICS COM Call 53,400 5,115 n/a n/a n/a
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F SAGE THERAPEUTICS COM Call 11,200 796 n/a n/a n/a
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-12 2016-06-30 13F SAGE THERAPEUTICS COM Call 393,900 11,868 n/a n/a n/a
2016-05-11 2016-03-31 13F SAGE THERAPEUTICS COM Call 0 0 n/a n/a n/a
2016-02-12 2015-12-31 13F SAGE THERAPEUTICS COM Call 0 0 n/a n/a n/a
2015-11-13 2015-09-30 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-18 2015-06-30 13F SAGE THERAPEUTICS COM Call 3,000 219 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-03-31 13F/A SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM Put 0 0 n/a n/a n/a
2023-09-21 2021-12-31 13F/A SAGE THERAPEUTICS COM Put 9,700 9,600.00 413 10,200.00 n/a n/a n/a
2022-02-14 2021-12-31 13F SAGE THERAPEUTICS COM Put 9,700 413 n/a n/a n/a
2021-12-17 2021-09-30 13F/A SAGE THERAPEUTICS COM Put 100 4 n/a n/a n/a
2023-09-21 2021-09-30 13F/A SAGE THERAPEUTICS COM Put 100 -99.72 4 -99.80 n/a n/a n/a
2021-11-15 2021-09-30 13F SAGE THERAPEUTICS COM Put 100 4 n/a n/a n/a
2021-08-20 2021-06-30 13F/A SAGE THERAPEUTICS COM Put 35,900 2,039 n/a n/a n/a
2023-09-21 2021-06-30 13F/A SAGE THERAPEUTICS COM Put 35,900 -36.80 2,039 -52.03 n/a n/a n/a
2021-08-16 2021-06-30 13F SAGE THERAPEUTICS COM Put 3,590,000 2,039 n/a n/a n/a
2023-09-21 2021-03-31 13F/A SAGE THERAPEUTICS COM Put 56,800 46.02 4,251 26.33 n/a n/a n/a
2021-05-14 2021-03-31 13F SAGE THERAPEUTICS COM Put 56,800 4,251 n/a n/a n/a
2023-09-21 2020-12-31 13F/A SAGE THERAPEUTICS COM Put 38,900 480.60 3,365 720.73 n/a n/a n/a
2021-02-16 2020-12-31 13F SAGE THERAPEUTICS COM Put 38,900 3,365 n/a n/a n/a
2020-11-13 2020-09-30 13F SAGE THERAPEUTICS COM Put 6,700 410 n/a n/a n/a
2020-05-15 2020-03-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F SAGE THERAPEUTICS COM Put 65,400 -12.92 4,721 -55.19 n/a n/a n/a
2019-11-13 2019-09-30 13F SAGE THERAPEUTICS COM Put 75,100 19.78 10,536 -8.22 n/a n/a n/a
2019-08-14 2019-06-30 13F SAGE THERAPEUTICS COM Put 62,700 -25.71 11,480 -14.48 n/a n/a n/a
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM Put 84,400 486.11 13,424 873.46 n/a n/a n/a
2019-02-14 2018-12-31 13F SAGE THERAPEUTICS COM Put 14,400 1,379 n/a n/a n/a
2017-11-14 2017-09-30 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM Put 27,500 3,337.50 2,190 3,742.11 n/a n/a n/a
2017-05-15 2017-03-31 13F SAGE THERAPEUTICS COM Put 800 57 n/a n/a n/a
2017-02-14 2016-12-31 13F/A SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM Put 65,900 -84.06 3,035 -75.64 n/a n/a n/a
2016-08-12 2016-06-30 13F SAGE THERAPEUTICS COM Put 413,500 12,459 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.